Enliven Therapeutics, Inc. (ELVN): SCHEDULE 13D/A filed Jun 17, 2026

Form type

SCHEDULE 13D/A

Filing date

Jun 17, 2026

Accession number

0000947871-26-000636

Filer

Enliven Therapeutics, Inc. (CIK 1672619)